2m 2m 2m 2m 2m 2m 2m
ADMA Biologics (ADMA)
NASDAQ
$9.00+$0.03 (+0.32%)
Price as of Jul 14, 2026 5:14 AM EDT- $2.1BMarket Cap
- -51.98%1-Year Change
- BiotechnologyIndustry
ADMA Biologics (ADMA)
$9.00+$0.03 (+0.32%)
ADMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.97 | ||
Change | -$0.11 (-1.21%) | ||
Open | $9.16 | ||
High | $9.21 | ||
Low | $8.88 | ||
Previous Close | $9.08 | ||
Volume | 2,874,364 | ||
30-Day Average Volume | 3,600,852 | ||
1-Week Change | -2.07% | ||
1-Month Change | 9.26% | ||
1-Year Change | -51.98% | ||
3-Year Change | 157.02% | ||
5-Year Change | 518.62% | ||
Fundamentals | |||
Shares Outstanding | 231.8M | ||
Total Assets | $665.2M | ||
Market Cap | $2.1B | ||
Enterprise Value | $2.1B | ||
Period: QTR TTM FY | |||
Revenue | $114.5M | ||
Net Income | $45.3M | ||
Free Cash Flow | $55.7M | ||
EBIT | $57.1M | ||
EBITDA | $59.0M | ||
Net Working Capital | $437.6M | ||
EPS | $0.19 | ||
Enterprise Value/EBITDA | 36 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 5 | ||
P/E | 47 | ||
PEG | -7 | ||
Price/Free Cash Flow | 37 | ||
Price/Operating Cash Flow | 36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue